Caricamento...
Macrophage migration inhibitory factor promotes resistance to glucocorticoid treatment in EAE
OBJECTIVE: Glucocorticoids (GCs) are used as standard treatment for acute attacks of multiple sclerosis (MS). However, GCs eventually lose efficacy and do not prevent disease progression. Macrophage migration inhibitory factor (MIF) is the only known proinflammatory cytokine induced by GCs that inhi...
Salvato in:
| Pubblicato in: | Neurol Neuroimmunol Neuroinflamm |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529283/ https://ncbi.nlm.nih.gov/pubmed/26280015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000139 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|